| Date Filed | Type | Description |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| APPLIED GENETIC TECHNOLOGIES CORP reports a 0% stake in Applied Genetic Techno Corp |
| 02/14/2017 |
SC 13G/A
| Axovant Sciences Ltd. reports a 0% stake in Axovant Sciences Ltd. |
| 02/14/2017 |
SC 13G/A
| ASSEMBLY BIOSCIENCES, INC. reports a 0% stake in Assembly Biosciences, Inc. |
| 02/14/2017 |
SC 13G/A
| AQUINOX PHARMACEUTICALS, INC reports a 0% stake in Aquinox Pharmaceuticals, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/14/2017 |
SC 13G/A
| Sage Therapeutics, Inc. reports a 0% stake in Sage Therapeutics, Inc. |
| 02/14/2017 |
SC 13G/A
| ESPERION THERAPEUTICS INC reports a 0% stake in Esperion Therapeutics Inc New |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/14/2017 |
SC 13G/A
| Quotient Ltd reports a 0% stake in Quotient Limited |
| 02/14/2017 |
SC 13G/A
| Wright Medical Group N.V. reports a 0% stake in Wright Medical Group NV |
| 02/14/2017 |
SC 13G/A
| SUNESIS PHARMACEUTICALS INC reports a 0% stake in Sunesis Pharmaceuticals, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/14/2017 |
SC 13G/A
| Zeltiq Aesthetics Inc reports a 0% stake in Zeltiq Aesthetics, Inc. |
| 02/14/2017 |
SC 13G/A
| Sientra, Inc. reports a 0% stake in Sientra, Inc. |
| 02/14/2017 |
SC 13G/A
| Visium Asset Management, LP reports a 0% stake in Ascendis Pharma A/S |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/14/2017 |
SC 13G/A
| Pacira Pharmaceuticals, Inc. reports a 0% stake in Pacira Pharmaceuticals, Inc. |
| 02/14/2017 |
SC 13G/A
| BIO BLAST PHARMA LTD. reports a 0% stake in Bio Blast Pharma Ltd. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/14/2017 |
SC 13G/A
| Lipocine Inc. reports a 0% stake in Lipocine Inc. |
| 02/14/2017 |
SC 13G/A
| LA JOLLA PHARMACEUTICAL CO reports a 0% stake in La Jolla Pharmaceutical Company |
| 02/14/2017 |
SC 13G/A
| Health Insurance Innovations, Inc. reports a 0% stake in Health Insurance Innovations, Inc. |
| 02/14/2017 |
SC 13G/A
| Enzymotec Ltd. reports a 0% stake in Enzymotec Ltd. |
| 02/14/2017 |
SC 13G/A
| SUNOVION CNS DEVELOPMENT CANADA ULC reports a 0% stake in Cynapsus Therapeutics Inc. |
| 02/14/2017 |
SC 13G/A
| Visium Asset Management, LP reports a 0% stake in NephroGenex, Inc. |
| 07/21/2016 |
SC 13G/A
| Quotient Ltd reports a 0% stake in Quotient Limited |
| 02/08/2016 |
SC 13G
| Visium Asset Management, LP reports a 6.5% stake in La Jolla Pharmaceutical Company |
| 10/16/2013 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 08/05/2013 |
SC 13G
| MARATHON BAR CORP reports a 9.9% stake in Lipocine Inc. |
| 04/22/2013 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|